Global surge in fake, substandard medical products, medicines

Worldwide reports indicate a surge in the availability and type of fraudulent medical products intended to exploit the fears of consumers.

According to The Transnational Alliance to Combat Illicit Trade (TRACIT), there is a growing availability of fake, falsified and substandard medical and healthcare products and medicines.  These ineffective, fraudulent products undermine public health and efforts to stem the COVID-19 pandemic.

Worldwide reports indicate a surge in the availability and type of fraudulent medical products intended to exploit the fears of consumers, which includes illicit offerings of falsified versions of treatments such as Hydroxychloroquine and Azithromycin that will harm or kill already vulnerable patients. Joint operations by the World Customs Organization, Europol and Interpol have resulted in a significant increase in seizures of counterfeit and unauthorized face masks and hand sanitizers.

“Emergency response measures to protect people from the COVID-19 virus must include the urgent need to protect them from fake, falsified and substandard medical products and medicines,” said TRACIT Director-General Jeffrey Hardy. “Someone wearing a falsified or substandard surgical face mask is not only at risk of exposure, but it creates a false sense of security that can actually accelerate the spread to others.”

TRACIT’s product warning list includes fake, falsified and substandard medical products such as surgical masks, hydro-alcoholic gels, testing kits and thermometers.  Also listed for increased vigilance are high demand healthcare and consumer products prone to counterfeiting, including cleaning solutions, toilet paper, anti-bacterial wipes, indoor sports equipment, refrigeration appliances, food products and reading materials.

TRACIT called for immediate action by governments, law enforcement, Internet platforms and brand owners

“Once we get past this crisis, we’ll need to double our efforts to prevent counterfeiting and falsification of medical products and medicines,” said Hardy. “This must start with stronger provisions for preventing the availability of illicit products online and stronger measures to keep illicit pharmaceuticals out of the physical supply chain, including postal and express carrier infrastructures.”

Lee Kok Leong

Lee Kok Leong

Kok Leong, executive editor, has overall editorial responsibility for the direction and focus of Maritime Fairtrade. He has two decades of working experiences, including holding senior regional roles in business-to-business (B2B) print and online publications. He enjoys his work as a journalist, and regards it as a calling.

The best maritime news and insights delivered to you.

Here's what you can expect from us:

  • News & key insights covering the maritime industry
  • Expert analysis and opinions on maritime corruption and more
  • Exclusive interviews